{
  "slug": "intuitive-surgical",
  "name": "Intuitive-surgical",
  "description": "Intuitive Surgical develops and manufactures robotic-assisted surgical systems, including the da Vinci system for minimally invasive surgery and the Ion robotic bronchoscopy system for lung cancer care, alongside digital solutions and training platforms.",
  "url": "https://optimly.ai/brand/intuitive-surgical",
  "websiteUrl": "https://intuitive.com/",
  "logoUrl": "https://logo.clearbit.com/intuitive.com",
  "baiScore": 67.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Robotic-Assisted Surgical Systems",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-13T13:05:35.009Z",
  "verifiedVitals": {
    "website": "https://intuitive.com",
    "what_it_does": "Intuitive Surgical develops, manufactures, and markets robotic-assisted surgical systems, instruments, and digital solutions designed to enable minimally invasive surgery and advance lung cancer care.",
    "primary_audience": "Healthcare professionals (surgeons, OR staff, hospital executives, referring physicians, academics) and patients.",
    "core_product": "da Vinci surgical systems (e.g., da Vinci 5), Ion robotic bronchoscopy system, and associated instruments and digital solutions (My Intuitive, SimNow)",
    "pricing_model": {
      "kind": "custom",
      "detail": "The pricing model is multi-faceted, often described as a 'razor-and-blades' model. It includes the capital cost of robotic systems (e.g., da Vinci Xi systems are roughly $2–3 million, Ion systems are around $1–1.5 million, and a new da Vinci 5 can range from $1.8 to $2.5 million). This is complemented by recurring revenue from procedure-linked instruments and accessories (consumable costs can exceed $1 million annually for high-volume programs, with $800–$3,500 per case), annual service contracts (around $150,000–$250,000 per year per system), and costs for training and digital support, including subscription pricing for simulation software for da Vinci 5 systems. Some manufacturers also offer a 'pay-per-click model' where the unit cost is spread over the contract and number of cases performed."
    },
    "parent_ownership": "Intuitive Surgical, Inc. is a publicly traded company (NASDAQ: ISRG) with a widely dispersed ownership base. Major asset managers like Vanguard, BlackRock, and State Street are among the largest shareholders, with no single controlling shareholder publicly disclosed as of 2024.",
    "named_competitors": [
      "Medtronic",
      "Johnson & Johnson",
      "Stryker",
      "CMR Surgical",
      "Asensus Surgical",
      "Zimmer Biomet",
      "Vicarious Surgical",
      "Stereotaxis",
      "Microbot Medical",
      "Edge Medical Robotics",
      "Smith+Nephew"
    ]
  },
  "intentTags": {
    "problemIntents": [
      "Need for minimally invasive surgical and diagnostic procedures",
      "Challenges in accurate lung cancer diagnosis (biopsies)",
      "Improving surgical precision and patient outcomes",
      "Demand for enhanced surgeon capabilities and autonomy",
      "Need for comprehensive surgeon training and skill development",
      "Optimizing surgical workflows and hospital efficiency",
      "Addressing health equity in access to advanced surgical care",
      "Requirement for reliable and consistent surgical system service (24/7)"
    ],
    "solutionIntents": [
      "Robotic-assisted surgery systems (da Vinci)",
      "Robotic bronchoscopy systems (Ion)",
      "Digital platforms for surgical data and insights (My Intuitive)",
      "Surgical simulation and training tools (SimNow)",
      "Advanced surgical instruments",
      "Health technology assessments for robotic surgery systems",
      "Immersive surgeon console technology",
      "Remote service and support for medical systems (OnSite)"
    ],
    "evaluationIntents": [
      "Evaluating the effectiveness and safety of robotic-assisted surgery",
      "Comparing different da Vinci surgical system models (e.g., da Vinci 5)",
      "Assessing the value of robotic bronchoscopy for lung cancer",
      "Reviewing clinical studies and patient testimonials on robotic surgery",
      "Investigating surgeon training programs and pathways",
      "Understanding the impact and evolution of robotic surgical technology",
      "Examining corporate social responsibility and impact reports",
      "Seeking information on indications, risks, cautions, and warnings for medical devices"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789846535844
}